-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX THERAPEUTICS, INC. : CANACCORD GENUITY RAISES TARGET PRICE TO $68 FROM $60

Reuters·11/06/2026 14:46:07

Please log in to view news